X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (6111) 6111
Magazine Article (24) 24
Conference Proceeding (14) 14
Book / eBook (8) 8
Newsletter (8) 8
Newspaper Article (6) 6
Book Chapter (4) 4
Web Resource (4) 4
Reference (2) 2
Dissertation (1) 1
Publication (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (4153) 4153
cognition disorders - chemically induced (3621) 3621
male (3522) 3522
female (2654) 2654
animals (2458) 2458
neurosciences (1818) 1818
adult (1418) 1418
rats (1259) 1259
cognition (1233) 1233
middle aged (1138) 1138
psychiatry (1111) 1111
cognition - drug effects (1108) 1108
memory (1057) 1057
aged (1022) 1022
pharmacology & pharmacy (969) 969
brain (895) 895
neuropsychological tests (883) 883
mice (882) 882
disease models, animal (842) 842
clinical neurology (749) 749
maze learning - drug effects (652) 652
brain - drug effects (616) 616
cognition disorders - psychology (616) 616
alzheimers-disease (613) 613
risk factors (577) 577
cognitive ability (575) 575
memory disorders - chemically induced (575) 575
dose-response relationship, drug (572) 572
cognition disorders - drug therapy (553) 553
analysis (545) 545
cognition disorders - diagnosis (543) 543
adolescent (502) 502
time factors (492) 492
rats, wistar (488) 488
neurology (482) 482
research (481) 481
cognition disorders - physiopathology (479) 479
alzheimer's disease (467) 467
memory - drug effects (461) 461
hippocampus (455) 455
hippocampus - drug effects (440) 440
oxidative stress (437) 437
impairment (436) 436
cognition disorders - etiology (435) 435
rodents (431) 431
pregnancy (424) 424
child (423) 423
schizophrenia (421) 421
rats, sprague-dawley (409) 409
cognition disorders (405) 405
dementia (376) 376
behavior, animal - drug effects (370) 370
health aspects (368) 368
animal cognition (334) 334
brain - metabolism (334) 334
aged, 80 and over (328) 328
cognitive impairment (327) 327
cognition disorders - epidemiology (322) 322
hippocampus - metabolism (320) 320
toxicology (319) 319
cognition disorders - prevention & control (317) 317
oncology (313) 313
cognition & reasoning (311) 311
behavioral sciences (310) 310
analysis of variance (308) 308
chemotherapy (301) 301
cognition disorders - metabolism (299) 299
age factors (295) 295
neurotoxicity (290) 290
neurons (289) 289
care and treatment (288) 288
children (285) 285
treatment outcome (285) 285
mice, inbred c57bl (283) 283
cancer (282) 282
epilepsy (278) 278
cognitive function (274) 274
young adult (274) 274
psychology (261) 261
behavior (260) 260
research article (258) 258
antineoplastic agents - adverse effects (256) 256
brain - pathology (254) 254
life sciences (254) 254
prefrontal cortex (254) 254
biomedicine (253) 253
anticonvulsants - adverse effects (249) 249
double-blind method (248) 248
studies (248) 248
motor activity - drug effects (243) 243
cognition - physiology (242) 242
exposure (241) 241
child, preschool (238) 238
medicine (235) 235
inflammation (234) 234
psychomotor performance - drug effects (230) 230
prospective studies (229) 229
follow-up studies (224) 224
cognition disorders - pathology (223) 223
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Online Resources - Online (4) 4
Gerstein Science - Stacks (3) 3
Collection Dvlpm't (Acquisitions) - Closed Orders (2) 2
Robarts - Stacks (1) 1
UofT at Mississauga - Stacks (1) 1
UofT at Scarborough - Bindery (1) 1
UofT at Scarborough - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5869) 5869
French (134) 134
German (61) 61
Spanish (50) 50
Japanese (49) 49
Polish (22) 22
Portuguese (17) 17
Russian (17) 17
Dutch (15) 15
Chinese (11) 11
Norwegian (11) 11
Italian (10) 10
Swedish (8) 8
Danish (6) 6
Romanian (4) 4
Turkish (4) 4
Hungarian (3) 3
Hebrew (2) 2
Czech (1) 1
Dzongkha (1) 1
Finnish (1) 1
Lithuanian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of the American College of Cardiology, ISSN 0735-1097, 2016, Volume 67, Issue 20, pp. 2395 - 2410
.... SAMS is the most frequent SAS, and mild myalgia may affect 5% to 10% of statin users. Clinically important muscle symptoms, including rhabdomyolysis and statin-induced necrotizing autoimmune myopathy... 
Cardiovascular | Internal Medicine | rhabdomyolysis | skeletal muscle | interstitial lung disease | myopathy | C-REACTIVE PROTEIN | RANDOMIZED CONTROLLED-TRIALS | CARDIAC & CARDIOVASCULAR SYSTEMS | FORCE 2014 UPDATE | PRIMARY-PREVENTION TRIAL | INDUCED MUSCLE TOXICITY | INTERSTITIAL LUNG-DISEASE | CENTRAL-NERVOUS-SYSTEM | OF-THE-LITERATURE | CORONARY-HEART-DISEASE | TYPE-2 DIABETES-MELLITUS | Liver Function Tests | Sleep Wake Disorders - chemically induced | Hydroxymethylglutaryl-CoA Reductase Inhibitors - immunology | Myalgia - chemically induced | Humans | Hyperlipidemias - drug therapy | Risk Factors | Lung Diseases, Interstitial - chemically induced | Tendon Injuries - chemically induced | Necrosis - chemically induced | Brain - drug effects | Rupture - chemically induced | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Stroke - chemically induced | Cognition Disorders - etiology | Depression - chemically induced | Rhabdomyolysis - chemically induced | Antibodies - blood | Diabetes Mellitus - chemically induced | Acute Kidney Injury - chemically induced | Muscular Diseases - chemically induced | Testosterone - blood | Autoimmune Diseases - chemically induced | Hyperlipidemias - complications | Viral antibodies | Complications and side effects | Enzymes | Thiols | Antibodies | Diabetes | Cardiology | Statins | Cardiovascular agents | Creatine kinase | Muscles | Creatine | Respiratory tract diseases | Studies | Musculoskeletal system | Genotype & phenotype | Mortality | Clinical trials | Lipids | Clinical medicine
Journal Article
Epilepsia, ISSN 0013-9580, 08/2013, Volume 54, Issue 4, pp. 44 - 60
...Over the past decade, there has been increasing recognition that epilepsy is a spectrum disorder that is defined by spontaneous recurrent seizures... 
Biomarkers | Therapy | Animal models | Comorbidity | Epilepsy | DEPRESSIVE-LIKE BEHAVIOR | TEMPORAL-LOBE EPILEPSY | GENETIC ABSENCE EPILEPSY | ENVIRONMENTAL ENRICHMENT | KETOGENIC DIET | CLINICAL NEUROLOGY | TRAUMATIC BRAIN-INJURY | EARLY-LIFE SEIZURES | SPATIAL MEMORY | INDUCED STATUS EPILEPTICUS | IMMATURE RATS | Drugs, Investigational - adverse effects | Cognition Disorders - chemically induced | Humans | Drugs, Investigational - therapeutic use | Depressive Disorder - drug therapy | Neurocognitive Disorders - psychology | Anxiety Disorders - chemically induced | Migraine Disorders - chemically induced | Neurocognitive Disorders - drug therapy | Depressive Disorder - chemically induced | Quality of Life - psychology | Anxiety Disorders - drug therapy | Drug Evaluation, Preclinical | Cognition Disorders - psychology | Disease Models, Animal | Attention Deficit Disorder with Hyperactivity - chemically induced | Epilepsy - psychology | Translational Medical Research | Neurocognitive Disorders - diagnosis | Neurocognitive Disorders - chemically induced | Cognition Disorders - drug therapy | Anxiety Disorders - psychology | Attention Deficit Disorder with Hyperactivity - drug therapy | Drug Discovery | Migraine Disorders - drug therapy | Epilepsy - diagnosis | Cognition Disorders - diagnosis | Animals | Migraine Disorders - psychology | Attention Deficit Disorder with Hyperactivity - psychology | Epilepsy - drug therapy | Depressive Disorder - psychology | Analysis | Medical research | Quality of life
Journal Article
Addiction (Abingdon, England), ISSN 1360-0443, 01/2010, Volume 105, Issue 1, pp. 121 - 133
Background  `Recreational' use of ketamine is spreading rapidly among young people. In healthy individuals an acute dose of the N-methyl D-aspartate (NMDA)... 
cognition | learning and memory | ketamine | recreational use | Chronic use | NMDA receptor antagonist | dependence | depression | longitudinal | glutamate | addiction and substance abuse | Learning and memory | Recreational use | Ketamine | Longitudinal | Dependence | Depression | Cognition | Addiction and substance abuse | Glutamate | FREQUENT | DRUG-USE | INFREQUENT | PSYCHIATRY | SCHIZOPHRENIA | SUBSTANCE ABUSE | EXPERIENCES | K-HOLE | ECSTASY USERS | RECREATIONAL USERS | HEALTHY-VOLUNTEERS | WORKING-MEMORY | Memory - drug effects | Delusions - epidemiology | Follow-Up Studies | Cognition Disorders - chemically induced | Humans | Male | Memory Disorders - diagnosis | Educational Status | Statistics as Topic | Dissociative Disorders - epidemiology | Dose-Response Relationship, Drug | Dissociative Disorders - chemically induced | Ketamine - adverse effects | Psychiatric Status Rating Scales | Time Factors | Substance-Related Disorders - epidemiology | Adult | Female | Depressive Disorder - chemically induced | Depressive Disorder - epidemiology | Excitatory Amino Acid Antagonists - adverse effects | Self Medication - psychology | Cognition Disorders - psychology | Memory Disorders - epidemiology | Self Medication - statistics & numerical data | Excitatory Amino Acid Antagonists - pharmacology | Delusions - chemically induced | Neuropsychological Tests | Recognition (Psychology) - drug effects | Speech Disorders - chemically induced | Speech Disorders - epidemiology | Substance-Related Disorders - psychology | Ketamine - pharmacology | Cognition Disorders - epidemiology | Memory Disorders - chemically induced | Illegal drugs | Methyl aspartate | Substance abuse | Depression, Mental | Drug abuse | Mental depression | Cognitive ability | Mental health
Journal Article
The journal of clinical endocrinology and metabolism, ISSN 1945-7197, 2015, Volume 100, Issue 4, pp. 1256 - 1266
Journal Article
Addiction Biology, ISSN 1355-6215, 06/2008, Volume 13, Issue 2, pp. 264 - 275
Since the discovery of the endocannabinoid system, a growing body of psychiatric research has emerged focusing on the role of this system in major psychiatric disorders like schizophrenia (SCZ), bipolar disorder (BD... 
cannabis | initial prodromal state | bipolar disorder | Anxiety | schizophrenia | major depression | Schizophrenia | Bipolar disorder | Cannabis | Initial prodromal state | Major depression | BINOCULAR DEPTH INVERSION | SUBSTANCE-ABUSE | ANTERIOR CINGULATE CORTEX | YOUNG ADULTHOOD | BIOCHEMISTRY & MOLECULAR BIOLOGY | ENDOCANNABINOID SYSTEM | BIPOLAR AFFECTIVE-DISORDER | SUBSTANCE ABUSE | METABOTROPIC GLUTAMATE | RECEPTOR ANTAGONIST | ANTIDEPRESSANT-LIKE ACTIVITY | anxiety | CB1 RECEPTORS | Psychoses, Substance-Induced - psychology | Antipsychotic Agents - toxicity | Bipolar Disorder - chemically induced | Marijuana Abuse - psychology | Mood Disorders - psychology | Cognition Disorders - chemically induced | Humans | Bipolar Disorder - physiopathology | Anxiety Disorders - chemically induced | Cannabinoid Receptor Modulators - physiology | Drug Interactions | Psychoses, Substance-Induced - physiopathology | Schizophrenia - physiopathology | Cannabinoids - toxicity | Marijuana Abuse - physiopathology | Cognition Disorders - psychology | Mood Disorders - chemically induced | Depressive Disorder, Major - physiopathology | Schizophrenia - chemically induced | Affect - drug effects | Cognition Disorders - physiopathology | Affect - physiology | Brain - physiopathology | Risk Factors | Anxiety Disorders - psychology | Bipolar Disorder - psychology | Brain - drug effects | Depressive Disorder, Major - chemically induced | Depressive Disorder, Major - psychology | Animals | Signal Transduction - drug effects | Receptor, Cannabinoid, CB1 - drug effects | Signal Transduction - physiology | Mood Disorders - physiopathology | Dronabinol - toxicity | Anxiety Disorders - physiopathology | Marijuana | Index Medicus
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2016, Volume 375, Issue 18, pp. 1717 - 1725
Journal Article
JNCI : Journal of the National Cancer Institute, ISSN 1460-2105, 2010, Volume 102, Issue 15, pp. 1114 - 1130
Testicular cancer represents the most curable solid tumor, with a 10-year survival rate of more than 95%. Given the young average age at diagnosis, it is... 
LONG-TERM SURVIVORS | CISPLATIN-INDUCED CYTOTOXICITY | ETOPOSIDE-INDUCED CYTOTOXICITY | PATIENTS RECEIVING CISPLATIN | QUALITY-OF-LIFE | RANDOMIZED CONTROLLED-TRIAL | GERM-CELL-CANCER | UMCG Approved | CORONARY-ARTERY-DISEASE | SINGLE NUCLEOTIDE POLYMORPHISMS | GENOME-WIDE ASSOCIATION | CARCINOMA-IN-SITU | BLEOMYCIN HYDROLASE GENE | ONCOLOGY | ATM SEQUENCE VARIANTS | RADIATION-INDUCED DAMAGE | Testicular Neoplasms - mortality | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Survivors - statistics & numerical data | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Fatigue - chemically induced | Pulmonary Fibrosis - genetics | Antineoplastic Agents - administration & dosage | Cardiovascular Diseases - genetics | Young Adult | Infertility, Male - genetics | Renal Insufficiency - chemically induced | Antineoplastic Agents - adverse effects | Employment | Adult | Paresthesia - chemically induced | Platinum Compounds - adverse effects | Renal Insufficiency - genetics | Genetic Predisposition to Disease | Genome-Wide Association Study | Neoplasm Recurrence, Local - prevention & control | Risk Assessment | Paresthesia - genetics | Survival Rate | Clinical Trials as Topic | Models, Statistical | Cognition - drug effects | Evidence-Based Medicine | Neoplasms, Second Primary - prevention & control | Testicular Neoplasms - drug therapy | Pulmonary Fibrosis - chemically induced | Quality of Life | Testicular Neoplasms - psychology | Cardiovascular Diseases - chemically induced | Platinum Compounds - administration & dosage | Infertility, Male - chemically induced | Population Surveillance | Cancer survivors | Care and treatment | Demographic aspects | Genetic aspects | Diagnosis | Research | Social aspects | Testicular cancer | Cancer | Index Medicus
Journal Article